Status:
COMPLETED
Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)
Lead Sponsor:
Pfizer
Conditions:
Bacterial Infections
Eligibility:
All Genders
Brief Summary
To collect the efficacy and safety information of Zithromax-SR related to their appropriate use in daily practice.
Detailed Description
All the patients whom an investigator prescribes the first Azithromycin SR should be registered within 14 days.
Eligibility Criteria
Inclusion
- Male or female subjects diagnosed with skin and soft tissue infection, sexually-transmitted infection, and infection of the oral.
- Subjects must have no prior experience with Azithromycin SR.
Exclusion
- Patients not administered Azithromycin SR.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
502 Patients enrolled
Trial Details
Trial ID
NCT00998309
Start Date
October 1 2009
End Date
January 1 2011
Last Update
May 1 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.